Wilms tumor in an 11-year-old with hemihyperplasia [4]

American Journal of Medical Genetics, Part A

Volumn 139 A, Issue 2, 2005, Pages 165-166

  Carré, Amanda ^a   Frantz, Christopher N ^b   Weksberg, Rosanna ^c   Nicholson, Linda ^b   Ciarlo, Lynn ^b   Zackai, Elaine H ^d   Gripp, Karen W ^b  

^a ARCADIA UNIVERSITY   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; DOXORUBICIN; VINCRISTINE;

ANAMNESIS; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HEMIHYPERTROPHY; HUMAN; LETTER; NEPHROBLASTOMA; PRIORITY JOURNAL; SCHOOL CHILD; CHILD; FEMALE; GROWTH DISORDER;

CHILD; FEMALE; GROWTH DISORDERS; HUMANS; WILMS TUMOR;

EID: 33645864963     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.31004     Document Type: Letter

References (17)

1. Aherne W, Buck P. 1971. The potential cell doubling time in neuroblastoma and nephroblastoma. Br J Cancer 25:691-696.
2. Beckwith JB. 1983. Wilms tumor and other renal tumors of childhood: A selective review from the National Wilms Tumor Study Pathology Center. Hum Pathol 14:481-492.
3. Beckwith JB. 1998a. Children at increased risk for Wilms tumor: Monitoring issues. J Pediatr 132(3):377-379.
4. Beckwith JB. 1998b. Nephrogenic rests and the pathogenesis of Wilms tumor: Developmental and clinical considerations. Am J Med Genet 79:268-273.
5. Breslow NE, Beckwith JB. 1982. Epidemiologic features of Wilms tumor: Results of the National Wilms Tumor Study. J Natl Cancer Inst 68:429-436.
6. Choyke P, Siegel M, Craft A, Green DM, DeBaun MR. 1999. Screening for Wilms tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy. Med Pediatr Oncol 32(3):196-200.
7. Cohen MM Jr, Neri G, Weksberg R. 2002. Hemihyperplasia (hemihypertrophy). In: Overgrowth syndromes. New York: Oxford University Press. pp 32-37.
8. DeBaun MR, Tucker MA. 1998. Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry. J Pediatr 132:398-400.
9. DeBaun MR, Siegel M, Choyke P. 1998. Nephromegaly in infancy and early childhood: A risk factor for Wilms tumor in Beckwith-Wiedemann syndrome. J Pediatr 132(3):401-404.
10. DeBaun MR, Niemitz EL, McNeil DE, Brandenburg SA, Lee MP, Feinberg AP. 2002. Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Hum Genet 70:604-611.
11. Green DM, Breslow N, Beckwith JB, Norkool P. 1993. Screening of children with hemihypertrophy, aniridia, and Beckwith-Wiedemann syndrome in patients with Wilms tumor: A report from the National Wilms Tumor Study. Med Pediatr Oncol 21:188-192.
12. Hoyme HE, Seaver LH, Jones KL, Procopio F, Crooks W, Feingold M. 1998. Isolated hemihyperplasia (hemihypertrophy): Report of a prospective multicenter study of the incidence of neoplasia and review. Am J Med Genet 79:274-278.
13. Huff V. 1998. Wilms tumor genetics. Am J Med Genet 79:260-267.
14. Martin RA, Grange DK, Zehnbauer B, DeBaun MR. 2005. LIT1 and H19 methylation defects in isolated hemihyperplasia. Am J Med Genet 134A:129-131.
15. Schneider K. 2002. Hereditary cancer syndromes. In: Counseling about cancer. 2nd edn. New York: Wiley-Liss. pp 78, 111-112.
16. Shackney SE, McCormack GW, Cuchural GJ. 1978. Growth rate patterns of solid tumors and their relation to responsiveness to therapy: An analytical review. Ann Intern Med 89:107-121.
17. Wiedemann HR. 1983. Tumors and hemihypertrophy associated with Wiedemann-Beckwith syndrome. Eur J Pediatr 141:129.